Bank Hapoalim B.M. (BKHYY)

Revance Therapeutics Revenue

Bank Hapoalim B.M. had revenue of 5.43B ILS in the quarter ending March 31, 2025, with 6.35% growth. This brings the company's revenue in the last twelve months to 21.59B, up 11.10% year-over-year. In the year 2024, Bank Hapoalim B.M. had annual revenue of 21.27B with 9.04% growth.

• Revenue (ttm): 21.59B ILS
• Revenue Growth: +11.10%
• P/S Ratio: 4.28
• Revenue / Employee: 2.55M ILS
• Employees: 8,480
• Market Cap: 24.79B USD

Revenue Chart

* This company reports financials in ILS.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	21.27B	1.76B	9.04%
Dec 31, 2023	19.50B	1.55B	8.63%
Dec 31, 2022	17.95B	2.34B	15.00%
Dec 31, 2021	15.61B	4.38B	38.98%
Dec 31, 2020	11.23B	-699.00M	-5.86%